Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Phase 1 Completed
40 enrolled
A Study of Patients Receiving High-Dose Rate Brachytherapy
Phase 2 Completed
43 enrolled 13 charts
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Phase 2 Completed
40 enrolled 13 charts
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Phase 2 Completed
30 enrolled 15 charts
Assessment of Screening Modalities for Gynecologic Cancers
Completed
118 enrolled
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
Completed
1,932 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled
Extended Follow-up of Columbia, MO Serum Bank Participants
Completed
6,720 enrolled
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Completed
745 enrolled
Molecular Staging of Endometrial Cancer
Completed
5,492 enrolled
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
Completed
6,086 enrolled
Bone Mineral Density and Subsequent Cancer Risk
Completed
15,595 enrolled
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
Phase 1 Completed
77 enrolled
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
52 enrolled 10 charts
Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
31 enrolled 13 charts
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Phase 1/2 Completed
384 enrolled 23 charts
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
49 enrolled 13 charts
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
53 enrolled 15 charts
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Phase 2 Completed
73 enrolled 13 charts
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Completed
33 enrolled
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Phase 2 Completed
62 enrolled 7 charts
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
18 enrolled
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
Phase 2 Completed
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer
Phase 3 Completed
2,300 enrolled
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Phase 1 Completed
41 enrolled
Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
Phase NA Completed
250 enrolled
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Phase 3 Completed
400 enrolled
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
Phase 1 Completed
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Phase 2 Completed
Thalidomide in Treating Patients With Gynecologic Sarcomas
Phase 2 Completed
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Phase 1 Completed
18 enrolled
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Phase 1 Completed
28 enrolled
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Phase 1 Completed
15 enrolled
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
60 enrolled
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
Phase 2 Completed
60 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Phase 1 Completed
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
Phase 2 Completed